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Abstract
Background: The non-human primate (NHP) research community has been intensely interested
in obtaining whole-genome expression arrays for their work. Recently, novel approaches were
used to generate the DNA sequence information for a rhesus GeneChip. To test the reliability of
the rhesus GeneChip across different centers, RNA was isolated from five sources: cerebral
cortex, pancreas, thymus, testis, and an immortalized fibroblast cell line. Aliquots of this RNA were
sent to each of three centers: Yerkes National Primate Research Center, Oregon National Primate
Research Center and the University of Nebraska Medical Center. Each center labeled the samples
and hybridized them with two rhesus macaque GeneChips. In addition, rhesus samples were
hybridzed with human GeneChips to compare with samples hybridized with the rhesus GeneChip.
Results: The results indicate that center effects were minimal and the rhesus GeneChip appears
highly reliable. To test the validity of the rhesus GeneChip, five of the most differentially expressed
genes among tissues identified in the reliability experiments were chosen for analysis with
Quantitative PCR. For all 5 genes, the qPCR and GeneChip results were in agreement with regard
to differential expression between tissues. Significantly more probesets were called present when
rhesus samples were hybridized with the rhesus GeneChip than when these same samples were
hybridized with a human GeneChip.
Conclusion: The rhesus GeneChip is both a reliable and a valid tool for examining gene
expression and represents a significant improvement over the use of the human GeneChip for
rhesus macaque gene expression studies.
Background
The non-human primate (NHP) research community has
been intensely interested in obtaining whole-genome
expression arrays for their work. The recent production of
a rhesus macaque GeneChip (Affymetrix, Santa Clara, CA)
now satisfies this need [1].
Novel approaches were used to generate the DNA
sequence information for the rhesus GeneChip. In 2005,
when the rhesus macaque GeneChip was in the design
stage, the percent of the total genes in the rhesus macaque
genome covered by the ESTs was quite small. In addition,
the rhesus macaque genome sequences were at an early
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stage of assembly and with limited redundancy. To over-
come these limitations, we used a targeted PCR approach
to acquire necessary sequences for the probes for over
5,000 genes [2]. All human last exons were identified and
aligned with Probe Selection Region (PSR) sequences
obtained from Affymetrix. Primers were designed that
flanked the PSRs. These primers were used to amplify
orthologous PSRs in rhesus macaques from rhesus
genomic DNA. The PCR products were cloned, sequenced
and deposited in GenBank. In an in silico version of our
targeted PCR approach, sequences from an early draft of
the Baylor Rhesus Genome assembly were aligned with
human PSRs and information for probe design extracted.
Using primarily these two sources of sequence informa-
tion, a whole genome rhesus macaqe expression Gene-
Chip was created by Affymetrix. The targeted acquisition
of the 3' gene sequence information used for the produc-
tion of the rhesus macaque GeneChip is unique among
the Affymetrix GeneChips.
The rhesus macaque GeneChip uses 52,000 probesets to
monitor the expression of over 47,000 transcripts, includ-
ing transcripts with multiple polyadenylation sites. Relia-
bility and reproducibility are major issues that must be
addressed to successfully apply microarray technology to
biomedical experiments [3,4]. They are particularly
important when researchers want to compare and inte-
grate microarray experiments from multiple laboratories
[5-7]. Due to the time and expense associated with NHP
experiments, it is critical that the results generated in one
center be comparable with results at another.
Given the novel strategies underlying the design of the
rhesus macaque GeneChip, we felt it was important to test
its reliability and validity. To test the reliability of the rhe-
sus GeneChip across different centers, RNA was isolated
from five sources: cerebral cortex, pancreas, thymus, testis,
and an immortalized fibroblast cell line. Two aliquots of
RNA from each tissue type were sent to each of three cent-
ers: Yerkes National Primate Research Center, Oregon
National Primate Research Center and the University of
Nebraska Medical Center. Each center labeled the two
aliquots individually and hybridized them to two separate
rhesus macaque GeneChips. The results indicate that
center effects were minimal and the rhesus GeneChip
appears highly reliable. To test the validity of the rhesus
GeneChip, five of the most differentially expressed genes
among tissues identified in the reliability experiments
were chosen for analysis with Quantitative PCR. The
results indicated the rhesus GeneChip provides valid
information.
Prior to the production of the rhesus GeneChip, many
investigators used various human expression arrays with
rhesus samples [8]. Although useful in obtaining some
information, studies indicated that performing these
cross-species hybridizations were resulting in the loss of
considerable data [9,10]. We wanted to determine
whether more probesets would be called present when
rhesus samples were hybridized with the rhesus Gene-
Chip in comparison to the human GeneChip. We found
the rhesus GeneChip was superior to the human Gene-
Chip for use with rhesus samples in all five tested samples.
Results
Quality assessment
Affymetrix GCOS quality control parameters – the back-
ground levels, the range of the present percentage, the
scaling factor values, the 3'/5' ratios of housekeeping
genes and the signal intensities of spiked-in hybridization
controls were all within acceptable levels as described by
Affymetrix for the data from the cerebral cortex, fibroblast,
testis and thymus experiments. The scaling factor (Table
1) and the NUSE value (Figure 1) indicated that the data
from the experiments involving pancreas samples was of
lower quality than the experiments involving the other
four tissues. The scaling factors of the pancreas arrays were
larger than any of the other samples for each lab and some
of the scaling factors for the pancreas results were three
fold larger than the average, which is above the tolerance
threshold suggested by Affymetrix. The NUSE medians
and the interquartile ranges (IQR) of the pancreas arrays
were larger than those of the other arrays, indicating that
the data from the pancreas arrays should be treated with
caution.
Table 1: Scaling factors (SF) of 30 arrays hybridized to Affymetrix GeneChips. Table 1 presents the scaling factors (SF) of all 30 arrays, 
where SF was calculated by setting up the Target Intensity (TGT) to be 100.
Oregon Array Cor1 Cor2 Fib1 Fib2 Pan1 Pan2 Tes1 Tes1 Thy1 Thy2
SF 1.29 1.19 0.96 1.22 3.60 3.54 0.91 0.95 1.05 1.04
Nebraska Array Br1 Br2 Fib1 Fib2 Pan1 Pan2 Tes1 Tes1 Thy1 Thy2
SF 0.92 1.09 1.05 1.20 4.58 3.88 0.94 0.77 1.28 1.27
Yerkes Array Br1 Br2 Fib1 Fib2 Pan1 Pan2 Tes1 Tes1 Thy1 Thy2
SF 1.13 0.84 0.65 1.09 1.75 2.13 0.89 0.75 0.92 0.80
Cor = cererbral cortex, Fib = fibroblast, Pan = pancreas, Tes = testis and Thy = thymus. 1 and 2 are two technical replicates.
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NUSE boxplotFigure 1
NUSE boxplot. After RMA preprocessing, the standard errors were standardized across arrays and then plotted to assess 
the data quality. x axis: the first letter "Or, Neb and Yrk" stands for three laboratories from the centers of Oregon, Nebraska 
and Yerkes, respectively. The second letter "B, F, P, T, H" represents the tissues of Brain (Cerebral Cortex), Fibroblast, Pan-
creas, Testis and Thymus, respectively. The third letter "1 and 2" are the two replicated measurements for each RNA extract.
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Correlation analysis
Correlation analysis is useful for detecting outlier arrays
and can provide valuable information about phenotypic
characteristics of the data (e.g., replicate, tissue). Figure 2
presents a heat map of array-array correlation coefficients
for the rhesus data, where the Spearman rank correlation
coefficient was computed to quantify the degree of simi-
larity between each pair of arrays. This plot was generated
using the Bioconductor library affyQCReport [11]. The
smallest correlation coefficient was 0.72, indicating good
quality of the data. It was observed that pairs of arrays had
stronger correlation within tissues than correlation
between tissues regardless of laboratories, showing good
reproducibility of the hybridizations across three centers.
Precision assessment
In order to assess precision, we plotted the difference
between replicate probeset signals to summarize precision
for the data. This procedure was done for each tissue, from
each laboratory (Figure 3). All boxplots were centered
around zero and the interquartile range (IQR) values were
small, indicating good precision.
Reliability of the rhesus GeneChip at different centers
One of the basic aims of an expression array experiment is
to identify differentially expressed genes (DE genes)
between samples. In this study, we conducted a "signifi-
cance analysis of microarrays" (SAM) [12] to identify
genes that are differentially expressed across five tissues
for each laboratory. We then evaluated the agreement
between laboratories in terms of the DE gene identifica-
tion. Many investigators consider approximately 1% of all
probesets to be differentially expressed [5,13]. We there-
fore examined the 500 most differentially expressed
probesets out of 52,000 (figure 4). The overall agreement
between laboratories is 71% (355/500). The agreement
between any two laboratories is slightly higher with the
values around 80% (from 0.78 to 0.84).
To further assess the reproducibility across laboratories,
we drew a correspondence at the top (CAT) plot [5]. A
CAT curve is created by plotting the proportion of genes in
common between Centers against the number of DE
genes. A CAT plot provides more information than a Venn
diagram because it shows the "dynamic" agreement
between two or more Centers. Figure 5 displays the CAT
plot of DE genes for the three Centers. The values of agree-
ment at the sizes 100, 200, 300, 400 and 500 are 0.73,
0.71, 0.68, 0.69 and 0.71, respectively.
Validation of the rhesus GeneChip
To validate the rhesus macaque GeneChip using a differ-
ent measure of gene expression, five genes, each of which
was highly expressed in one tissue, were chosen for quan-
titative real-time PCR (qRT-PCR) analysis (Figure 6). A
gene's relative expression (e.g., fold change measurements
between two tissues) is commonly used as the metric for
the validation purpose [5,14,15].
The performance of the Affymetrix rhesus array and the
qRT-PCR assay were compared in terms of each gene's rel-
ative expression (i.e., log2 fold change) between tissues
(Figure 6). For each selected gene, the fold change repre-
sents the ratio of the expression of the gene in its highly-
expressed tissue to its expression in each of the other tis-
sues. All fold change measurements from the qRT-PCR
assay were considerably larger than 0, indicating each of
the selected genes was highly expressed in one of five tis-
sues.
For all 5 genes, the qPCR and GeneChip results were in
agreement with regard to differential expression between
tissues. With respect to each individual gene, on the aver-
age, the largest fold change measurements from the
Affymetrix rhesus array occurred in the gene PRSS2, which
was also consistent with the results from the qRT-PCR
results. In most cases, the fold change measurements from
the qRT-PCR assay were larger than the corresponding
ones from the Affymetrix rhesus array, which is often
observed [16,17].
Comparison of the rhesus GeneChip with the human 
GeneChip for studying gene expression in rhesus macaque 
samples
To determine how the rhesus GeneChip compares with a
human GeneChip for detecting gene expression in rhesus
samples, two samples (each) from the same rhesus
macaque sources described above (cerebral cortex, fibro-
blast, pancreas, testis and thymus) were hybridized with
the Affymetrix human (HGU133plus2.0) GeneChip. For
every tissue and replicate, there was a much higher Percent
Present call with the rhesus macaque GeneChip than with
the human GeneChip (figure 7). The mean difference
between the Percent Present calls with the rhesus macaque
and human GeneChips was significant at the .001 level.
Discussion
We assessed the reliability of the Affymetrix Rhesus
Macaque GeneChip, between three laboratories using five
tissues. The reliability of the Rhesus GeneChip was excel-
lent; similar to the reported reliability of the human Gene-
Chip [4]. This is important because macaques are in short
supply and quite expensive. The proven reliability of the
macaque GeneChip will facilitate large study designs uti-
lizing animals from different centers.
We also assessed the validity of the rhesus GeneChip by
comparing the expression patterns of a group of genes that
were found to be differentially expressed in the GeneChip
experiments with a qRT-PCR assay. The results indicate
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Heat Map Plot of Array-array Correlation CoefficientsFigure 2
Heat Map Plot of Array-array Correlation Coefficients. The Spearman correlation coefficient was computed to quan-
tify the degree of similarity between each pair of arrays. For the array name, "Or, Neb and Yrk" stands for three laboratories 
from the centers of Oregon, Nebraska and Yerkes, respectively while "B, F, P, T, H" represent the tissues of Cortex, Fibrob-
last, Pancreas, Testis and Thymus, respectively. "1 and 2" are the two replicated measurements for each RNA extract.
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that the rhesus GeneChip yields accurate and valid data.
This is important because the design of this GeneChip was
unique. The sequences that were used to choose the
probes were almost all genomic. The results from this
study validate the idea that, in closely related species,
probes from last exons can be successfully used. Exhaus-
tive, expensive EST projects are not necessary to create
genome wide gene chips when last exons of the target spe-
cies can be identified.
The development of a reliable, valid rhesus macaque
GeneChip should facilitate many important studies. Our
results indicate that using the rhesus GeneChip with rhe-
sus samples represents a significant improvement over use
of the human GeneChip. It is expected that researchers in
the fields of AIDS, vaccine development, transplant biol-
ogy, stem cell/reproductive biology and the neurosciences
will be able to use the rhesus macaque GeneChip to make
important breakthroughs.
Conclusion
The rhesus macaque GeneChip is reliable across centers
and is a valid tool for measuring gene expression. It offers
significant advantages in sensitivity as compared to the
human GeneChip for expression analysis.
Methods
RNA isolation and GeneChip hybridization
The RNA samples were extracted from four tissues and
one cell line of rhesus macaques: immortalized fibroblasts
(Nebraska), cerebral cortex (Yerkes), pancreas (Oregon),
testis (Oregon) and thymus (Oregon). Two aliquots of
each RNA sample were distributed to each of three cent-
ers: Oregon National Primate Research Center, Yerkes
National Primate Research Center and the University of
Nebraska Medical Center. Each center labeled and hybrid-
ized samples using standard Affymetrix protocols. The
Rhesus Macaque Genome GeneChip that consists of over
52,000 probe sets (Affymetrix, Santa Clara, CA) was used
for all hybridizations. A total of 30 hybridizations were
performed (three centers x five samples x two replicates)
using Affymetrix reagents (Affymetrix). In addition, two
aliquots of each sample were hybridized with the human
GeneChip (HGU133plus2.0).
Venn diagram of the 500 most differentially expressed genes across three laboratoriesFigure 4
Venn diagram of the 500 most differentially 
expressed genes across three laboratories. The SAM 
algorithm was applied to arrays from each laboratory, pre-
processed by RMA, to select the 500 most differentially 
expressed genes for each center. This Venn diagram shows 
the number of genes that were found in common among the 
centers.
Boxplot of the difference between sample replicatesFigure 3
Boxplot of the difference between sample replicates. 
After RMA preprocessing, probeset signal differences 
between sample replicates were plotted to assesss precision. 
x axis: the first letters "Or, Neb and Yrk" stand for three lab-
oratories from the centers of Oregon, Nebraska and Yerkes, 
respectively. The second letters "B, F, P, T, H" represent 
Brain (Cerebral Cortex), Fibroblast, Pancreas, Testis and 
Thymus, respectively.
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Total RNA was extracted from these tissues using Trizol
Reagent (Invitrogen, Carlsbad, CA) as described by the
manufacturer: fibroblast, pancreas, thymus, testis, and
cerebral cortex. RNA was treated with DNase 1 (Invitro-
gen) and followed by a cleanup procedure using Qiagen
RNeasy mini kit (Qiagen, Valencia, CA) according to the
manufacturer's protocols. The RNA quality was assessed
using an Agilent 2100 Bioanalyzer and RNA 6000 Nano
LabChips (Agilent, Palo Alto, CA). All RNA samples
showed a 260/280 ratio between 1.8 and 2.0 and 28S:18S
ratio of 1.5 and higher. Target RNA labeling, hybridiza-
tion and post-hybridization processing were performed
following the Affymetrix GeneChip Expression Analysis
manuals (Affymetrix). The 5 g of RNA sample was first
reverse-transcribed using T7-Oligo(dT) Promoter Primer
and SuperScript II in the first-strand cDNAs synthesis reac-
tion. Following RNase H-mediated second-stranded
cDNA synthesis, the double-stranded cDNAs were puri-
fied by use of a GeneChip sample clean-up module and
served as templates in the generation of biotinylated com-
plementary RNAs (cRNAs) in the presence of T7 RNA
Polymerase and a biotinylated nucleotide analog/ribonu-
cleotide mix by in vitro transcription (IVT) reaction. The
biotinylated cRNAs were cleaned up, fragmented, and
hybridized to the rhesus macaque expression arrays at
45°C for 16 h with constant rotation at 60 rpm. The
microarrays were washed and stained with Affymetrix flu-
idics stations and scanned on Affymetrix scanner 3000.
The images were processed to collect raw data with Gene-
Chip Operating Software (GCOS).
Affymetrix GeneChip preprocessing
We exported .cel files from Affymetrix GCOS software and
preprocessed them with robust multiarray analysis (RMA)
[18]. Three steps were taken to process the probe-level
data of the Affymetrix oligo arrays: background correc-
tion, normalization and probe-level summarization at the
log2-scale. Instead of the default RMA background correc-
tion, we used MAS 5.0 (Affymetrix) to correct for back-
ground because, in our experience, probe-level intensities
are more normally distributed after MAS 5.0 background
correction. Quantile normalization was applied to arrays
from each Center separately to control for variation in
hybridizations at the different Centers. Intensity values
from all 30 arrays were combined and summarized by
RMA to extract probeset-level data. Data quality was
assessed using the affy Bioconductor package [19]. The
raw data (30 .CEL files) has been uploaded to th GEO
repository [20] (GEO accession number is GSE7094).
Quality assessment
Various quality assessment measures were calculated to
assess the quality of the experiments, some of which were
outputted from Affymetrix GCOS/MAS 5.0, such as the
background levels, the range of the present percentage, the
scaling factor values, the 3'/5' ratios of housekeeping
genes (e.g., -actin, GAPDH), and the signal intensities of
spike-in hybridization controls. Two byproducts from
RMA --- RNA degradation indices and NUSE values ---
were also used to assess the quality of the experiments
[21].
The scaling factor is the amount of scaling applied to the
values for each array to make its intensity mean equal to a
pre-specified value, which is called Target intensity value
(TGT); the default value is usually 100. In practice, the
trimmed (e.g., 0.02) intensity mean is commonly com-
puted for each experiment. The assumption behind SF is
that gene expression does not change significantly for the
vast majority of transcripts in an experiment. Affymetrix
suggests that the SF values for the arrays should be within
3-fold of each another. There are a variety of reasons for
an array's SF value to deviate from the others, such as the
quality and amount of starting material, issues with RNA
labeling and scanning, and issues with array manufacture.
NUSE is calculated by standardizing RMA-estimated
standard errors across arrays. In this way, the differences
in variability between probesets can be adjusted and the
Pairwise CAT plotFigure 5
Pairwise CAT plot. Each of the dashed lines represents 
CAT curves that indicate the agreement between pairs of 
laboratories while the solid line indicates the agreement 
across alll three laboratories. These results were obtained by 
plotting the proportion of common genes between laborato-
ries (Y axis) and the number of differentially expressed genes 
(X axis).
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Agreement within genes for fold changes determined by Affymetrix rhesus GeneChip and quantitative real-time PCRFigure 6
Agreement within genes for fold changes determined by Affymetrix rhesus GeneChip and quantitative real-
time PCR. The "rhesus-array Fold Change" is defined as: Mean Signal of the target gene in its exclusively-expressed tissue/
Mean Signal of the target gene in the other tissue, while the gene signal was estimated from the Affymetrix rhesus arrays. The 
"qRT-PCR Fold change" is defined as: 2 Ct Ct = (Ct of the target gene in its exclusively-expressed tissue – Ct of the control 
gene in its exclusively-expressed tissue) – (Ct of the target gene in the other tissue – Ct of the control gene in the other tis-
sue), while the threshold cycle (Ct) was the average value from five replicates from the qRT-PCR assay. Please note the Ct 
value of the gene PRSS2 in the tissue of Fibroblast was missing due to the undetermined readings. Thus, the maximum cycle 
number 40 was assigned to approximate the value.
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boxplot of these standardized values can be used to com-
pare chip qualities [21].
Correlation analysis
The rank-based Spearman correlation coefficient was
computed to quantify the degree of similarity between
each pair of arrays. The results were visualized with a heat
map plot. This plot was generated using the Bioconductor
library affyQCReport.
Identification of differentially expressed genes
To identify genes that are differentially expressed among
five tissues, we conducted "significance analysis of micro-
arrays" (SAM) proposed by Tusher, Tibshirani and Chu
[12]. SAM is a supervised learning program for cDNA and
oligo microarrays. It identifies genes with statistically sig-
nificant changes in expression by assimilating a set of
gene-specific t-tests, while the standard deviation is
adjusted by adding a small positive constant to ensure
that the variance of the calculated score is independent of
gene expression. To account for the multiple comparisons
and overcome the difficulties of having few replicates,
SAM performs a random permutation among experiments
and sets up a cut-off threshold (e.g., at 5%) to identify the
significant genes. For the cut-off threshold, SAM estimates
the false discovery rate (FDR) by counting the number of
random-permutated genes which exceeds the cut-off
threshold in the original setting.
Quantitative real-time PCR
Real time PCR reactions were performed on an ABI 7500
PCR Thermal Cycler using RQ (Relative Quantitation)
software (Applied Biosystems, Foster City, CA, USA). The
reaction mix contained 1 g of cDNA, 900 nM primers
(ABI) and 250 nM probe (ABI), and 25 l of TaqMan Uni-
versal PCR Master Mix (ABI) which contains AmpliTaq
Gold DNA Polymerase, giving a final volume of 50 l. The
thermal cycler conditions were as follows: two initial
steps: 2 minutes @ 50°C, 10 minutes @ 95°C, Cycling
conditions: 40 cycles of 15 seconds @ 95°C and 1 minute
@ 60°C. All mRNA expression values were normalized to
GAPDH. Primer and probe sequences for genes being

































Comparison of Percent Present calls of rhesus samples hybridized with huma  and rhesus macaqu  GeneChipsFigure 7
Comparison of Percent Present calls of rhesus sam-
ples hybridized with human and rhesus macaque 
GeneChips. Percent Present called after hybridization of 
the rhesus samples with the human Affymetrix GeneChip 
(hgu133plus2) (dark bars) and the rhesus macaque GeneChip 
(light bars). Y – axis indicates the percent of total probesets 
scored present using the standard Affymetrix default param-
eters. X – axis indicates the results obtained with each rhe-
sus macaque sample. "B, F, P, T, H" represent Brain 
(Cerebral Cortex), Fibroblast, Pancreas, Testis and Thymus, 
respectively. Numbers represent each of two replicates for 
each tissue sample.
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All of the above primer and probe sequences were gener-
ated and prepared by ABI custom gene expression assay
service using rhesus macaque mRNA sequences.
Percent present computation
The Affymetrix MAS 5.0 algorithm was used to generate
the detection call information for each probe set, where
the Affymetrix default values (0.15, 0.04 and 0.06) were
used for parameters tau, alpha1 and alpha2, respectively.
Percent present for each array was computed as the
number of probesets called Present out of the total
number of probesets.
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